Thursday, September 19, 2013
Publication and contact
mice with streptozotocin-induced diabetes as models of diabetic nephropathy
Phlorizin pretreatment in
mice with streptozotocin-induced diabetes make them useful as models to help
identify new treatments for diabetic nephropathy. In mice, high doses of
streptozotocin induce diabetes but also cause acute kidney injury (AKI),
which makes the mice unsuitable as models of diabetic nephropathy. In the
kidneys of mice given a high dose of streptozotocin, AKI markers were
associated with downregulation of solute carrier family 2 facilitated glucose
transporter member 2 (Slc2a2; Glut2). In mouse models of
streptozotocin-induced diabetes, pretreatment with the competitive sodium-glucose cotransporter 2
(SGLT2) inhibitor phlorizin
increased Glut2 levels and decreased both renal uptake of streptozotocin and
consequent AKI compared with vehicle pretreatment. Next steps could include
confirming that the mice develop diabetic nephropathy and using them to
evaluate therapeutic candidates.
Published online Sept. 19, 2013
B. et al. J. Biol. Chem.; published online Aug. 11, 2013;
Contact: Jeroen Declercq, Catholic University Leuven, Leuven, Belgium
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]